Our featured expert notes the importance of optimizing the use of vesicular monoamine transporter 2 (VMAT2) inhibitors and addressing comorbidities...READ MORE
Tardive dyskinesia (TD) and drug-induced parkinsonism are both movement disorders that are associated with dopamine receptor–blocking agents. While...READ MORE
patient care perspectives by Michael C. Heinrich, MD
The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat......READ MORE
At the 2022 ASCO Annual Meeting, several studies highlighted the promise of combination strategies and optimal incorporation of immune checkpoint i...READ MORE
Immuno-oncology (IO) has transformed the treatment paradigm across multiple tumor types and histologies. Proceedings from the 2022 ASCO Annual Meet...READ MORE
